Text Size

December 2015 Message from LDNscience® Founder

Dear LDNscience® Visitor,

Moshe bw

Good health is so important but it isn’t always easy finding the solutions to your health issues.

Go back fifteen years--remember how difficult it was to find out useful information about off-label medications such as Low Dose Naltrexone (LDN)? Many patients, perhaps yourself included, were desperately searching for some answers and they weren’t there.

LDNscience’s Beginnings


When I first began looking at LDN some fifteen years ago, no clinical trial had been undertaken anywhere with LDN. Many physicians are unwilling to prescribe a medication that has not been rigorously tested through clinical trials. This is particularly so when the medication is to be used off-label (not for its approved use). I recognized the potential of LDN, saw the need for proper research and took action.

Thirteen years have passed since I initiated the first ever clinical trial of LDN, at Hershey Medical Center, Penn State University. Since then many reputable institutions have followed our lead in performing trials and publishing reports about LDN including:

  • Cleveland Clinic (USA)
  • Drexel University (USA)
  • Erasmus Medical Center (Netherlands)
  • Loyola University (USA)
  • University of Erlangen- Nuremberg (Germany)
  • SUNY Upstate (USA)
  • Stanford University (USA)
  • London University Hospital (Canada)
  • Ecole Polytechnique Laboratoire (France)
  • Brown University (USA)
  • University of California (USA)
  • San Raffaele Scientific Institute (Italy)
  • Tel Aviv Medical Center (Israel)

What impact have these trials had on patient lives? It is estimated that at least 300,000 patients worldwide are using LDN today! That is a staggering number considering that no pharmaceutical company is promoting LDN and most doctors learn about it from their patients.

I launched LDNscience.org nearly six years to provide patients with the information they need to make truly informed choices about their health and transform their lives. I believe it’s the most powerful ever patient-led initiative and a model that can be replicated many times, with the potential to revolutionize medical practice.

Remember, what a breath of fresh air LDNscience.org has been in the world of medical research and how it helped you find the solutions you needed? The need for that information is growing and technology moves on so it is time to redesign our site to cater to the rapidly increasing demands.

LDNscience® Relaunch


We want to give the power over your health decisions back to you. Don’t leave it solely up to the pharmaceutical companies who are profit-centered or your doctor who may just be too busy. Here is YOUR opportunity to be part of our goal to help the next 1 million patients. Support the creation of the new and improved LDNscience.org - set to launch in February 2016 - in one of two ways:

Become a CureLeader by making a (tax-deductible) donation and have your name, picture, personal message and link etched on the Platinum, Diamond, Gold or Silver sections of the virtual Board of CureLeaders.

$1000+ - Platinum CureLeader
$750 - Diamond CureLeader
$500 - Gold CureLeader
$250 - Silver CureLeader

Alternatively, become a CureSupporter and setting up a recurring donation of at least $9 per month.

Both CureLeaders and CureSupporters will receive an invitation to subscribe to our VIP Group List and receive an immediate alert when new content or research is added to our system. Avoid the delay of having to wait for the next newsletter; the latest research can be in your hands today…

LDNscience.org has been freely supporting patient well-being for six years--now we need your support. Your donation will help us to keep on helping others. Without your support patient-led initiatives such as LDNscience.org cannot survive.

Click here now to make your secure donation (tax-deductible in the US) and make sure that LDNscience.org can continue to provide free and trusted health information.

Donations can also be mailed to:
MedInsight Research Institute
1732 1st Ave #23222,
New York, NY 10128


Wishing you all excellent health,

Moshe Rogosnitzky
LDNscience.org A MedInsight Project

Visit my Blog

Return to Newsletter

Join Our Supporters >>

We thank all our sponsors who have supported our life-saving work!


Diamond Level Sponsors

Emily Ross, NY, NY, USA

James Madison, Paris, France

Samuel and Deborah Marks, London, England

Join Our Supporters >>

Gold level Sponsors

Adam Marcus, LA, CA, USA

Jeff and Suzie Miles, Dallas, TX, USA

Sam Johnson, Monsey, NY, USA

Debbie and Dave Gross, Cleveland, OH, USA

Join Our Supporters >>

Silver Level Sponsors

Kathy Dwight, London, England

Dr. Kay Austen, Los Angeles, CA, USA

David and Jody Broom, Concord, NH, USA

Ed Martin, Denver, CO, USA

Moshe and Chanie Gross, Baltimore, MD, USA

Adam Pepper, Santa Cruz, CA, USA

Jennifer Numan, Seattle, WA, USA

Dona White, Long Island, NY, USA

Steve and Emily Long, Toronto, Ontario, Canada

Richard Holbrook, Egginton Derby, Derbyshire, United Kingdom

Karsin Family, Hawaii, USA

Patty Russell, Iowa, USA


»»We are currently seeking an Outreach Ambassador to help us raise public awareness. If you are savvy about social media and passionate about the cause, please take a moment to learn more about this volunteer position

Support LDN Research

Be The FIRST to Know about Important News and Updates. Join our Newsletter Subscribers Now
Please wait